{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:58:13Z","timestamp":1762459093706},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,7,11]],"date-time":"2013-07-11T00:00:00Z","timestamp":1373500800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1007\/s00223-013-9756-0","type":"journal-article","created":{"date-parts":[[2013,7,10]],"date-time":"2013-07-10T04:42:44Z","timestamp":1373431364000},"page":"288-295","source":"Crossref","is-referenced-by-count":2,"title":["The Effect of Endogenous Parathyroid Hormone in Iliac Bone Structure and Turnover in Healthy Postmenopausal Women"],"prefix":"10.1007","volume":"93","author":[{"given":"D. Sudhaker","family":"Rao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nayana","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saroj","family":"Palnitkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shijing","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,7,11]]},"reference":[{"key":"9756_CR1","first-page":"801","volume":"34","author":"BC Silva","year":"2011","unstructured":"Silva BC, Costa AG, Cusano NE, Kousteni S, Bilezikian JP (2011) Catabolic and anabolic actions of parathyroid hormone on the skeleton. J Endocrinol Invest 34:801\u2013810","journal-title":"J Endocrinol Invest"},{"key":"9756_CR2","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s001980200026","volume":"13","author":"MR Rubin","year":"2002","unstructured":"Rubin MR, Cosman F, Lindsay R, Bilezikian JP (2002) The anabolic effects of parathyroid hormone. Osteoporos Int 13:267\u2013277","journal-title":"Osteoporos Int"},{"key":"9756_CR3","first-page":"184","volume":"163","author":"A Khan","year":"2000","unstructured":"Khan A, Bilezikian J (2000) Primary hyperparathyroidism: pathophysiology and impact on bone. CMAJ 163:184\u2013187","journal-title":"CMAJ"},{"issue":"Suppl 2","key":"9756_CR4","first-page":"N95","volume":"17","author":"EF Eriksen","year":"2002","unstructured":"Eriksen EF (2002) Primary hyperparathyroidism: lessons from bone histomorphometry. J Bone Miner Res 17(Suppl 2):N95\u2013N97","journal-title":"J Bone Miner Res"},{"issue":"Suppl 2","key":"9756_CR5","first-page":"N98","volume":"17","author":"PD Miller","year":"2002","unstructured":"Miller PD, Bilezikian JP (2002) Bone densitometry in asymptomatic primary hyperparathyroidism. J Bone Miner Res 17(Suppl 2):N98\u2013N102","journal-title":"J Bone Miner Res"},{"key":"9756_CR6","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1210\/jc.84.5.1562","volume":"84","author":"DW Dempster","year":"1999","unstructured":"Dempster DW, Parisien M, Silverberg SJ, Liang XG, Schnitzer M, Shen V, Shane E, Kimmel DB, Recker R, Lindsay R, Bilezikian JP (1999) On the mechanism of cancellous bone preservation in postmenopausal women with mild primary hyperparathyroidism. J Clin Endocrinol Metab 84:1562\u20131566","journal-title":"J Clin Endocrinol Metab"},{"key":"9756_CR7","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/jbmr.5650070808","volume":"7","author":"M Parisien","year":"1992","unstructured":"Parisien M, Mellish RW, Silverberg SJ, Shane E, Lindsay R, Bilezikian JP, Dempster DW (1992) Maintenance of cancellous bone connectivity in primary hyperparathyroidism: trabecular strut analysis. J Bone Miner Res 7:913\u2013919","journal-title":"J Bone Miner Res"},{"key":"9756_CR8","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1359\/jbmr.1997.12.5.856","volume":"12","author":"SJ Silverberg","year":"1997","unstructured":"Silverberg SJ, Bilezikian JP (1997) Primary hyperparathyroidism: still evolving? J Bone Miner Res 12:856\u2013862","journal-title":"J Bone Miner Res"},{"key":"9756_CR9","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1210\/er.2004-0006","volume":"26","author":"AB Hodsman","year":"2005","unstructured":"Hodsman AB, Bauer DC, Dempster DW, Dian L, Hanley DA, Harris ST, Kendler DL, McClung MR, Miller PD, Olszynski WP, Orwoll E, Yuen CK (2005) Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. Endocr Rev 26:688\u2013703","journal-title":"Endocr Rev"},{"key":"9756_CR10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.bone.2008.09.019","volume":"44","author":"RR Recker","year":"2009","unstructured":"Recker RR, Bare SP, Smith SY, Varela A, Miller MA, Morris SA, Fox J (2009) Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1\u201384. Bone 44:113\u2013119","journal-title":"Bone"},{"key":"9756_CR11","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1210\/jc.2004-0028","volume":"89","author":"DS Rao","year":"2004","unstructured":"Rao DS, Phillips ER, Divine GW, Talpos GB (2004) Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab 89:5415\u20135422","journal-title":"J Clin Endocrinol Metab"},{"key":"9756_CR12","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.bone.2004.02.003","volume":"35","author":"O Sahota","year":"2004","unstructured":"Sahota O, Mundey MK, San P, Godber IM, Lawson N, Hosking DJ (2004) The relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover, and bone mineral density in postmenopausal women with established osteoporosis. Bone 35:312\u2013319","journal-title":"Bone"},{"key":"9756_CR13","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","volume":"2","author":"AM Parfitt","year":"1987","unstructured":"Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR (1987) Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595\u2013610","journal-title":"J Bone Miner Res"},{"key":"9756_CR14","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/jbmr.5650111219","volume":"11","author":"ZH Han","year":"1996","unstructured":"Han ZH, Palnitkar S, Rao DS, Nelson D, Parfitt AM (1996) Effect of ethnicity and age or menopause on the structure and geometry of iliac bone. J Bone Miner Res 11:1967\u20131975","journal-title":"J Bone Miner Res"},{"key":"9756_CR15","first-page":"3","volume-title":"Bone histomorphometry: techniques and interpretations","author":"DS Rao","year":"1983","unstructured":"Rao DS (1983) Practical approach to bone biopsy. In: Recker R (ed) Bone histomorphometry: techniques and interpretations. CRC Press, Boca Raton, pp 3\u201311"},{"key":"9756_CR16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.1805","volume":"28","author":"DW Dempster","year":"2013","unstructured":"Dempster DW, Compston JE, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR, Parfitt AM (2013) Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 28:2\u201317","journal-title":"J Bone Miner Res"},{"key":"9756_CR17","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/0026-0495(76)90124-4","volume":"25","author":"AM Parfitt","year":"1976","unstructured":"Parfitt AM (1976) The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone diseases. II. PTH and bone cells: bone turnover and plasma calcium regulation. Metabolism 25:909\u2013955","journal-title":"Metabolism"},{"key":"9756_CR18","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/0026-0495(76)90151-7","volume":"25","author":"AM Parfitt","year":"1976","unstructured":"Parfitt AM (1976) The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone disease. Part I of IV parts: mechanisms of calcium transfer between blood and bone and their cellular basis: morphological and kinetic approaches to bone turnover. Metabolism 25:809\u2013844","journal-title":"Metabolism"},{"key":"9756_CR19","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S8756-3282(00)00316-1","volume":"27","author":"AB Hodsman","year":"2000","unstructured":"Hodsman AB, Kisiel M, Adachi JD, Fraher LJ, Watson PH (2000) Histomorphometric evidence for increased bone turnover without change in cortical thickness or porosity after 2\u00a0years of cyclical hPTH (1\u201334) therapy in women with severe osteoporosis. Bone 27:311\u2013318","journal-title":"Bone"},{"key":"9756_CR20","doi-asserted-by":"crossref","first-page":"385","DOI":"10.4158\/EP.6.5.385","volume":"6","author":"Z Syed","year":"2000","unstructured":"Syed Z, Khan A (2000) Skeletal effects of primary hyperparathyroidism. Endocr Pract 6:385\u2013388","journal-title":"Endocr Pract"},{"key":"9756_CR21","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1677\/joe.1.06057","volume":"187","author":"JT Potts","year":"2005","unstructured":"Potts JT (2005) Parathyroid hormone: past and present. J Endocrinol 187:311\u2013325","journal-title":"J Endocrinol"},{"key":"9756_CR22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bone.2007.03.020","volume":"41","author":"DW Dempster","year":"2007","unstructured":"Dempster DW, Muller R, Zhou H, Kohler T, Shane E, Parisien M, Silverberg SJ, Bilezikian JP (2007) Preserved three-dimensional cancellous bone structure in mild primary hyperparathyroidism. Bone 41:19\u201324","journal-title":"Bone"},{"key":"9756_CR23","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1093\/gerona\/60.11.1414","volume":"60","author":"D Maggio","year":"2005","unstructured":"Maggio D, Cherubini A, Lauretani F, Russo RC, Bartali B, Pierandrei M, Ruggiero C, Macchiarulo MC, Giorgino R, Minisola S, Ferrucci L (2005) 25(OH)D serum levels decline with age earlier in women than in men and less efficiently prevent compensatory hyperparathyroidism in older adults. J Gerontol A 60:1414\u20131419","journal-title":"J Gerontol A"},{"key":"9756_CR24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00198-007-0456-3","volume":"19","author":"G Guardia","year":"2008","unstructured":"Guardia G, Parikh N, Eskridge T, Phillips E, Divine G, Rao DS (2008) Prevalence of vitamin D depletion among subjects seeking advice on osteoporosis: a five-year cross-sectional study with public health implications. Osteoporos Int 19:13\u201319","journal-title":"Osteoporos Int"},{"key":"9756_CR25","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1046\/j.1523-1755.63.s85.11.x","volume":"85","author":"C Gomez-Alonso","year":"2003","unstructured":"Gomez-Alonso C, Naves-Diaz ML, Fernandez-Martin JL, Diaz-Lopez JB, Fernandez-Coto MT, Cannata-Andia JB (2003) Vitamin D status and secondary hyperparathyroidism: the importance of 25-hydroxyvitamin D cut-off levels. Kidney Int Suppl 85:S44\u2013S48","journal-title":"Kidney Int Suppl"},{"key":"9756_CR26","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1001\/jama.294.18.2336","volume":"294","author":"L Steingrimsdottir","year":"2005","unstructured":"Steingrimsdottir L, Gunnarsson O, Indridason OS, Franzson L, Sigurdsson G (2005) Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. JAMA 294:2336\u20132341","journal-title":"JAMA"},{"key":"9756_CR27","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1210\/jc.2012-2020","volume":"97","author":"JC Gallagher","year":"2012","unstructured":"Gallagher JC, Yalamanchili V, Smith LM (2012) The effect of vitamin D on calcium absorption in older women. J Clin Endocrinol Metab 97:3550\u20133556","journal-title":"J Clin Endocrinol Metab"},{"key":"9756_CR28","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1172\/JCI27071","volume":"115","author":"LG Raisz","year":"2005","unstructured":"Raisz LG (2005) Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest 115:3318\u20133325","journal-title":"J Clin Invest"},{"issue":"Suppl 3","key":"9756_CR29","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s00198-002-1340-9","volume":"14","author":"E Seeman","year":"2003","unstructured":"Seeman E (2003) Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis. Osteoporos Int 14(Suppl 3):2\u20138","journal-title":"Osteoporos Int"},{"key":"9756_CR30","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s11914-008-0013-9","volume":"6","author":"S Kousteni","year":"2008","unstructured":"Kousteni S, Bilezikian JP (2008) The cell biology of parathyroid hormone in osteoblasts. Curr Osteoporos Rep 6:72\u201376","journal-title":"Curr Osteoporos Rep"},{"key":"9756_CR31","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1210\/jcem-70-4-930","volume":"70","author":"M Parisien","year":"1990","unstructured":"Parisien M, Silverberg SJ, Shane E, de la Cruz L, Lindsay R, Bilezikian JP, Dempster DW (1990) The histomorphometry of bone in primary hyperparathyroidism: preservation of cancellous bone structure. J Clin Endocrinol Metab 70:930\u2013938","journal-title":"J Clin Endocrinol Metab"},{"key":"9756_CR32","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1046\/j.1365-2265.2003.01722.x","volume":"58","author":"DS Rao","year":"2003","unstructured":"Rao DS, Wallace EA, Antonelli RF, Talpos GB, Ansari MR, Jacobsen G, Divine GW, Parfitt AM (2003) Forearm bone density in primary hyperparathyroidism: long-term follow-up with and without parathyroidectomy. Clin Endocrinol (Oxf) 58:348\u2013354","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9756_CR33","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1002\/jbmr.1627","volume":"27","author":"RI Gafni","year":"2012","unstructured":"Gafni RI, Brahim JS, Andreopoulou P, Bhattacharyya N, Kelly MH, Brillante BA, Reynolds JC, Zhou H, Dempster DW, Collins MT (2012) Daily parathyroid hormone 1\u201334 replacement therapy for hypoparathyroidism induces marked changes in bone turnover and structure. J Bone Miner Res 27:1811\u20131820","journal-title":"J Bone Miner Res"},{"key":"9756_CR34","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/B978-012088562-6\/50039-X","volume-title":"Dynamics of bone and cartilage metabolism","author":"JP Bilezikian","year":"2006","unstructured":"Bilezikian JP, Rubin MR (2006) Monitoring anabolic treatment. In: Seibel MJ, Robins SP, Bilezikian JP (eds) Dynamics of bone and cartilage metabolism. Academic Press, San Diego, pp 629\u2013647"},{"key":"9756_CR35","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa031975","volume":"349","author":"DM Black","year":"2003","unstructured":"Black DM, Greenspan SL, Ensrud KE, Palermo L, McGowan JA, Lang TF, Garnero P, Bouxsein ML, Bilezikian JP, Rosen CJ (2003) The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N Engl J Med 349:1207\u20131215","journal-title":"N Engl J Med"},{"key":"9756_CR36","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa035725","volume":"349","author":"JS Finkelstein","year":"2003","unstructured":"Finkelstein JS, Hayes A, Hunzelman JL, Wyland JJ, Lee H, Neer RM (2003) The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. N Engl J Med 349:1216\u20131226","journal-title":"N Engl J Med"},{"issue":"Suppl 5","key":"9756_CR37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00198-003-1477-1","volume":"14","author":"MB Schaffler","year":"2003","unstructured":"Schaffler MB (2003) Role of bone turnover in microdamage. Osteoporos Int 14(Suppl 5):73\u201380","journal-title":"Osteoporos Int"},{"key":"9756_CR38","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1210\/jc.85.6.2127","volume":"85","author":"M Horwitz","year":"2000","unstructured":"Horwitz M, Stewart A, Greenspan SL (2000) Sequential parathyroid hormone\/alendronate therapy for osteoporosis\u2014robbing Peter to pay Paul? J Clin Endocrinol Metab 85:2127\u20132128","journal-title":"J Clin Endocrinol Metab"},{"key":"9756_CR39","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/jbmr.1784","volume":"28","author":"S Hansen","year":"2012","unstructured":"Hansen S, Hauge EM, Jensen JE, Brixen K (2012) Differing effects of PTH 1\u201334, PTH 1\u201384 and zoledronic acid on bone microarchitecture and estimated strength in postmenopausal women with osteoporosis. An 18\u00a0month open-labeled observational study using HR-pQCT. J Bone Miner Res 28:736\u2013745","journal-title":"J Bone Miner Res"},{"key":"9756_CR40","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.bone.2008.10.037","volume":"44","author":"RL Jilka","year":"2009","unstructured":"Jilka RL, O\u2019Brien CA, Ali AA, Roberson PK, Weinstein RS, Manolagas SC (2009) Intermittent PTH stimulates periosteal bone formation by actions on post-mitotic preosteoblasts. Bone 44:275\u2013286","journal-title":"Bone"},{"key":"9756_CR41","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1359\/jbmr.2003.18.11.1932","volume":"18","author":"Y Jiang","year":"2003","unstructured":"Jiang Y, Zhao JJ, Mitlak BH, Wang O, Genant HK, Eriksen EF (2003) Recombinant human parathyroid hormone (1\u201334) (teriparatide) improves both cortical and cancellous bone structure. J Bone Miner Res 18:1932\u20131941","journal-title":"J Bone Miner Res"},{"key":"9756_CR42","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S8756-3282(97)00198-1","volume":"21","author":"L Zhang","year":"1997","unstructured":"Zhang L, Takahashi HE, Inoue J, Tanizawa T, Endo N, Yamamoto N, Hori M (1997) Effects of intermittent administration of low dose human PTH (1\u201334) on cancellous and cortical bone of lumbar vertebral bodies in adult beagles. Bone 21:501\u2013506","journal-title":"Bone"},{"key":"9756_CR43","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/jbmr.1497","volume":"27","author":"MG Ascenzi","year":"2011","unstructured":"Ascenzi MG, Liao VP, Lee BM, Billi F, Zhou H, Lindsay R, Cosman F, Nieves J, Bilezikian JP, Dempster DW (2011) Parathyroid hormone treatment improves the cortical bone microstructure by improving the distribution of type I collagen in postmenopausal women with osteoporosis. J Bone Miner Res 27:702\u2013712","journal-title":"J Bone Miner Res"},{"key":"9756_CR44","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/nmat1911","volume":"6","author":"K Tai","year":"2007","unstructured":"Tai K, Dao M, Suresh S, Palazoglu A, Ortiz C (2007) Nanoscale heterogeneity promotes energy dissipation in bone. Nat Mater 6:454\u2013462","journal-title":"Nat Mater"},{"key":"9756_CR45","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/jbmr.560","volume":"27","author":"E Donnelly","year":"2011","unstructured":"Donnelly E, Meredith DS, Nguyen JT, Gladnick BP, Rebolledo BJ, Shaffer AD, Lorich DG, Lane JM, Boskey AL (2011) Reduced cortical bone compositional heterogeneity with bisphosphonate treatment in postmenopausal women with intertrochanteric and subtrochanteric fractures. J Bone Miner Res 27:672\u2013678","journal-title":"J Bone Miner Res"},{"key":"9756_CR46","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1359\/jbmr.2001.16.10.1846","volume":"16","author":"DW Dempster","year":"2001","unstructured":"Dempster DW, Cosman F, Kurland ES, Zhou H, Nieves J, Woelfert L, Shane E, Plavetic K, Muller R, Bilezikian J, Lindsay R (2001) Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study. J Bone Miner Res 16:1846\u20131853","journal-title":"J Bone Miner Res"},{"key":"9756_CR47","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4103\/0022-3859.97171","volume":"58","author":"VN Shah","year":"2012","unstructured":"Shah VN, Bhadada SK, Bhansali A, Behera A, Mittal BR, Bhavin V (2012) Influence of age and gender on presentation of symptomatic primary hyperparathyroidism. J Postgrad Med 58:107\u2013111","journal-title":"J Postgrad Med"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-013-9756-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-013-9756-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-013-9756-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T21:43:26Z","timestamp":1563399806000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-013-9756-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,11]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["9756"],"URL":"https:\/\/doi.org\/10.1007\/s00223-013-9756-0","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,11]]}}}